Log In
BCIQ
Print this Print this
 

INT0010

  Manage Alerts
Collapse Summary General Information
Company IntelGenx Corp.
DescriptionImproved formulation of THC (dronabinol)
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$0.2M

0

0


 Deals Details
Get a free BioCentury trial today